首页|CircRNA在胃癌中的研究进展

CircRNA在胃癌中的研究进展

扫码查看
胃癌是最难治愈的癌症之一。近年来,由于饮食生活习惯的改变以及幽门螺杆菌感染等原因,导致胃癌发病趋于年轻化。胃癌发病早期没有典型的症状,诊断率较低,难以与慢性胃炎等消化系统疾病鉴别。临床上一直依靠肿瘤血清标志物检查胃癌,如癌胚抗原、糖类抗原199、糖类抗原72-4、胃蛋白酶原等,但这些标志物的灵敏度和特异度欠佳。环状RNA(CircRNA)是RNA大家族中的一员,具有闭合共价环特殊结构,其稳定性及保守性等较一般线性RNA高,有望成为胃癌早期诊疗的新型生物标志物或胃癌治疗的潜在靶点。本文对CircRNA的结构特点、生物学特性、生物学功能以及CircRNA对胃癌的预后评估等方面进行综述,以期为胃癌的早期检测和治疗提供依据。
Research progress of CircRNA in gastric cancer
Gastric cancer is one of the most difficult cancers to cure.In recent years,the incidence of gastric cancer tends to be younger due to the change of dietary and living habits as well as the infection of Helicobacter pylori.There are no typical symptoms in the early stage of gastric cancer,so the diagnosis rate is low and it is difficult to distinguish it from chronic gastritis and other digestive diseases.Clinically,we have been relying on tumor serum markers to detect gastric cancer,such as carcinoembryonic antigen,carbonhydrate antigen 199,carbonhydrate antigen 72-4,pepsinogen,etc.However,the sensitivity and specificity of these markers are not good,and circular RNA(CircRNA),which is a member of the RNA family,has a special structure of closed covalent ring,and has a higher stability and conservatism than the general linear RNAs,which is expected to become a new biomarker or potential biomarker for the early diagnosis of gastric cancer or the treatment of gastric cancer.It is expected to be a novel biomarker for early diagnosis and treatment of gastric cancer or a potential target for gastric cancer therapy.In this paper,the structural characteristics,biological properties,biological functions and prognostic evaluation of CircRNAs in gastric cancer are reviewed in order to provide a basis for the early detection and treatment of gastric cancer.

Gastric cancerCircular RNABiomarkerPrognosis

孟辉、张红伟

展开 >

内蒙古科技大学包头医学院,内蒙古包头 014010

内蒙古科技大学包头医学院第一附属医院消化内科,内蒙古包头 014010

胃癌 环状RNA 生物标志物 预后

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(19)